UNSPSC 51362800: Hypnotic quinazolines

Hypnotic drugs made from benzopyrimidines, or compounds consisting of two six-membered rings, one benzene, one pyrimidine ring.

UNSPSC 51362800 Hypnotic quinazolines is a Class code that shows a significant mismatch between its nominal pharmaceutical scope and recent state and local procurement activity. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—involves emergency-response and harm-reduction supplies rather than hypnotic quinazolines as a drug class. Naloxone is an opioid antagonist used to reverse overdose, not a sedative or anxiolytic agent within the quinazoline family. This procurement does not align with the code's stated product category, suggesting either miscoding by the issuing body or a data error in the opportunity classification.

Seminole County released the IFB on July 10, 2023, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract runs for an initial two-year term with a one-year renewal option; vendors must provide unit costs for each line item and comply with drug-free workplace certification, E-Verify requirements, and federal compliance obligations tied to potential FEMA funding. The code shows no additional recent state or local opportunities, suggesting minimal current activity under this classification for actual hypnotic-quinazoline procurement.